Porter C. Tyrosine kinase inhibitors in hematologic malignancy: should we be concerned?. OncoReview [Internet]. 2016Feb.23 [cited 2024Jun.27];6(1(21):11-3. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/470